Chevron (NYSE:CVX)’s $53 billion acquisition of Hess Corp (NYSE:HES). can now proceed after an arbitration panel ruled in favor of Hess in its dispute with Exxon Mobil Corp (NYSE:XOM).

Sarepta Therapeutics shares plunged premarket on Friday after the company disclosed another patient death linked to its gene therapy programs, this time during an early-stage trial for limb-girdle ...